期刊文献+

消瘤汤含药血清对人肝癌细胞HepG2凋亡相关因子表达的影响 被引量:5

Effects of the serum containing anti-cancer prescrirtion on expression of HepG2 apoptosis-associated factors
原文传递
导出
摘要 [目的]观察消瘤汤含药血清对人肝癌细胞HepG2凋亡相关因子表达的影响,进一步证实该方对肿瘤细胞的抑制作用,并初步探讨其诱导肝癌细胞凋亡的作用机制。[方法]给予昆明种小鼠中药煎剂灌胃3d后,制备消瘤汤鼠含药血清,将其作用于HepG2细胞,用四氮唑盐法(MTT法)检测含药血清对HepG2细胞增殖的抑制作用,通过流式细胞技术测定肿瘤细胞的凋亡情况,应用免疫组化法检测半胱氨酸蛋白酸3(Caspase-3)、B细胞淋巴瘤2(Bcl-2)蛋白表达水平。[结果]消瘤汤鼠含药血清作用于HepG2细胞72h后,对肿瘤细胞生长有明显抑制作用。流式细胞仪检测可见含药血清组在细胞G1/G0期前出现明显的凋亡峰,即"亚二倍体峰"。凋亡率为22.3%,明显高于对照组的1.05%(P<0.05)。免疫组化结果表明Caspase-3在含药血清干预后,表达明显增加,而Bcl-2在含药血清干预后,表达明显降低。[结论]消瘤汤可能通过激活Caspase-3及抑制Bcl-2的活性,从而诱导肝癌细胞凋亡,有效地抑制肝癌细胞生长,达到抗肿瘤的作用。 [-Objective]To investigate the effects of the serum containing anti-cancer prescription (ACP) on expression of apoptosis associated factors in human hepatoma carcinoma cell HepG2 to prove the inhibitory effect of serum containing ACP on the proliferation of HepG2 and to explore its effective mechanism of cell apoptosis, [Methods]The rats were administrated with the herbs and then the blood was collected to prepare serum containing ACP, the serum containing ACP was added to culture HepG2 cells. The MTT assay was used to examine the proliferation inhibitory activity and the flow cytometry was used to assay the apoptosis. Immunohistochemistry was used to detect the expression of Caspase-3 and Bcl-2 in the level of protein.[Results]The serum containg ACP has an obvious inhibitory effect on the proliferation of HepG2 for 72 hours. The results of the flow cytometry revealed that there was a remarkable apoptotic peak before G0-G1 phase after Dretreatment with the serum, hypodiploid peak, the rate of apoptosis was 22. 3%,which was higher than the control(1.05%) obviously. The results of the immunohistochemistry demonstrated the expression of Caspase-3 was increased, compared with the low expression of Bcl- 2,after treatment with the serum containg ACP. [Conclusion]The serum containing ACP has a significant inhibitory effect on the proliferation of HepG2. The mechanism of inducing cell apoptosis may be relevant to stimulate Caspase-3 and suppress Bcl-2.
出处 《中国中西医结合消化杂志》 CAS 2009年第3期171-174,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词 消瘤汤 HEPG2 细胞凋亡 半胱氨酸蛋白酸3 B细胞淋巴瘤2 ACP HepG2 apoptosis Caspase-3 Bcl-2
  • 相关文献

参考文献12

  • 1COHEN G M. Caspases: the executioners of apoptosis [J]. Biochem, 1997,326 : 1-- 16.
  • 2WANG J, LENARDO M J. Roles of Caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies [J]. J Cell Sci, 2000, 113:753--757.
  • 3BURLACU S. Regulation of apoptosis by Bcl-2 family proteins[J]. Cell Mol Med, 2003,7 : 249-- 257.
  • 4CHIU C T,YEH T S, HSU J C, et al. Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma[J]. Dig Dis Sci, 2003,48: 670-- 676.
  • 5CORY S, ADAMS J M. The Bcl2 family: regulators of the cellular life-or-death switch[J]. Nat Rev Cancer, 2002,2:647 656.
  • 6李仪奎.中药血清药理学实验方法的若干问题[J].中药新药与临床药理,1999,10(2):95-98. 被引量:263
  • 7ROHAYEM J, DIESTELKOETTER P, WEIGLE B, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein surviving in cancer patients[J]. Cancer Res, 2000,60 :1815-- 1817.
  • 8李玉中,王朝晖,王乃玉,王丽丽,邢文斌.Caspase-3在肝癌组织中的表达及其与HBV感染的关系[J].中国微生态学杂志,2006,18(4):280-281. 被引量:3
  • 9MASATO E, HIDEKI S, HIDEKI Y, et al. A caspaseactivated dnase that degrades DNA during apoptosis, and its inhibitor ICAD [J]. Nature, 1998,391 :~ 43-- 50.
  • 10KNILLOVA J, KOLAR Z. The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. I . Proteins of the Bcl-2 family and protein p53[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2003,147 : 3-- 10.

二级参考文献10

  • 1黄坚,陈长勋,李仪奎.用血清实验法观察小青龙汤对离体豚鼠气管平滑肌的作用[J].中药药理与临床,1995,11(6):12-13. 被引量:41
  • 2李仪奎 吴健宁.中药的血清药理研究方法.药理学进展[M].北京:科学出版社,1998.257-262.
  • 3田文艺.药物动力学参数手册[M].长沙:湖南科学技术出版社,1987,5..
  • 4STELLER H.Mechanism and genes of celluar suicide[J].Science,1995,267:1445-1449.
  • 5SHIN S,SUNG B J,CHO Y S,et al.An anti-apoptotic protein human surviving is a direct inhibitor of caspase-3 and-7[J].Biochemistry,2001,40:1117-1123.
  • 6DEGUEHI M,SHIRAKI K,INOUE H,et al.Expression of survivin during liver regeneration[J].Biochem Biophys Res Commune,2002,297(1):59-64.
  • 7SUZUKI A,ITO T,KAWANO,H,et al.Survivin initiates procaspase-3/p21 complex formation as a result of interaction with cdk4 to resist Fas-mediated cell death[J].Oncogene,2000,19(10):1346.
  • 8LIHUA M,SNORRI S,THORGEIRSSON,et al.Dominant role of hepatitis B Virus and cofactor role of aflatoxin in hepato-carcinogenesis in Qidong,China[J].Hepatotology,2002,36 (5):1214-1216.
  • 9MARUSAWA H,MATSUZAWA S,WELSH K,et al.HBXIP functions as a cofactor of survivin in apoptosis supperssion[J].EMBO J,2003,22 (11):2729-2740.
  • 10FISHER D E.Apoptosis in cancer therapy crossing the threshold[J].Cell,1994,78:539-542.

共引文献264

同被引文献55

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部